Dr. Aleena Banerji is Professor at Harvard Medical School and Clinical Director of the Allergy and Clinical Immunology Unit at MGH. She is known for her expertise in drug allergy, vaccine allergy, and angioedema. She has focused her career to improving the lives of patients with these conditions, pioneering innovative approaches to diagnosis and treatment. Early in her career, she recognized the unmet need for specialized drug allergy care and established a successful program at Massachusetts General Hospital, based on her extensive research involving patient data and novel treatment protocols.

Dr. Banerji has focused particular attention on the growing concern of chemotherapy allergies in cancer patients. She developed and refined risk stratification algorithms to accurately identify those with true allergies, enabling them to receive crucial chemotherapy treatments safely and effectively. To further expand access to this specialized care, she aims to expand the program, allowing oncologists in areas outside Boston to manage patients with chemotherapy allergies under the guidance of MGH allergy experts.

Throughout her career, Dr. Banerji has remained committed to advancing the field of allergy and immunology. Her work has not only transformed the lives of countless patients but has also significantly advanced the understanding and management of drug allergies, vaccine allergies, and angioedema.